Atlas Trials

Phase 1 Trial of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies

Clinical trial NCT01690741 · COMPLETED

Trial details

NCT number
NCT01690741
Sponsor
Immune System Key Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2013-12-01
Primary completion
2017-12-19
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.